BioStem Technologies, Inc.
BioStem Technologies, Inc. scores highest on Price (79) and lowest on Nitro (25). Its PosiPenta is 51.71 out of 100, around the middle of similar companies.
On the Penta Grid this week, BioStem Technologies, Inc. is Grid #256 of 837 in the Healthcare sector in United States, and Grid #1,682 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| BioStem Technologies, Inc. | 51.71 | 79 | 46 | 25 | 49 | 60 |
| Metagenomi Therapeutics, Inc. | 38.59 | 49 | 34 | 17 | 39 | 55 |
| Filana Therapeutics, Inc. | 40.75 | 45 | 53 | 15 | 67 | 25 |
| Estrella Immunopharma, Inc. | 41.19 | 0 | 42 | 21 | 88 | 55 |
| Aligos Therapeutics, Inc. | 34.56 | 40 | 27 | 34 | 37 | 35 |
| Impact BioMedical Inc. | 61.00 | 75 | 96 | 20 | 72 | 42 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 2.38 |
| P/B ratio | 1.41 |
EEarnings
| Trailing EPS | ₹83.35 |
| Forward EPS | ₹27.47 |
NNitro
| Price | 197.95 |
| 52-week high | 795.61 |
| 52-week low | 178.06 |
| Fall from 52-week high | 75.1% |
TTorque
| Return on equity (ROE) | -74.74% |
| Debt-to-equity | 0.04 |
AAnchor
| Beta (price swings) | 0.50 |
| Market cap | ₹369 Cr |
| Insider holding | 31.35% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is BioStem Technologies, Inc.'s PosiPenta score?
BioStem Technologies, Inc.'s PosiPenta is 51.71 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does BioStem Technologies, Inc. stand on the Penta Grid?
On the Penta Grid this week, BioStem Technologies, Inc. is Grid #256 of 837 in the Healthcare sector in United States, and Grid #1,682 of 4,000 in United States.
Which PosiPenta pillar is strongest for BioStem Technologies, Inc.?
Price (valuation), with a score of 79 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for BioStem Technologies, Inc.?
Nitro (momentum), with a score of 25 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.